NV
enVVeno Medical Corporation
NVNBW · OTC
$0.01 +0.00% (+$0.00)
Market Cap $141.5K
P/E Ratio -
Div. Yield -
ROE 61.45%
Bulios Fair Price
$0.01
42.9% upside
Current Price
$0.007
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NVNBW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.17x
P/B 0.00x
P/E N/A
Growth
100 /100
Growing Book val. growth 239.48%
EPS growth N/A
Rev. growth N/A
Profitability
5 /100
Weak Gross margin 18.97%
Net margin 2,705.05%
Op. margin 2,904.56%
Quality
0 /100
Poor ROIC 78.00%
ROE 61.45%
ROA 67.89%
Debt
100 /100
Low Debt/Equity 0.03x
Current ratio 13.12x
Net debt/EBITDA 0.04x
Stability
46 /100
Moderate Beta 1.10x
EPS volatility 45.27%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NVNBW
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Robert A. Berman
Employees
37
Headquarters
Irvine